[Retracted] High CHAF1A Expression Levels Are Positively-Correlated with PD-L1 Expression and Indicate Poor Prognosis in Gastric Cancer

Table 5

Univariate cox regression analysis of 140 gastric cancer patients.

Parameters	Univariate analysis
	value	HR (95% CI)
Gender
Female vs. male	0.836	1.082 (0.513–2.279)
Age (year)
≤ 65 vs. ＞ 65	0.651	1.168 (0.595–2.295)
CHAF1A expression
Low vs. high	0.021	1.175 (1.090–2.890)
Gastric history
No vs. yes	0.053	2.719 (0.988–7.487)
Smoking history
No vs. yes	0.920	1.036 (0.519–2.070)
Drinking history
No vs. yes	0.848	0.927 (0.428–2.008)
Weight loss
No vs. yes	0.340	1.398 (0.703–2.788)
Tumor location
Proximal	0.662
Distal
Total
Borrmann type
I, II vs. III, IV	0.003	2.864 (1.420–5.777）
Lauren type
Intestinal	0.382
Diffuse
Mixed
Tumor size (cm)
≤ 5 vs. ＞ 5	0.258	1.491 (0.747–2.979)
Grade of differentiation poor/moderate-poor.vs.moderate/well	0.398	1.341 (0.679–2.647)
T sstage
T1,T2 vs.T3,T4	0.144	3.387 (0.659–17.398)
N stage
N0,N1 vs.N2,3	0.001	3.947 (1.804–8.638)
M stage
M0 vs.M1	0.014	13.400 (1.692–106.142)
TNM stage
I,II vs. III,IV	0.177	1.990 (0.733–5.400)
Pathological type
Adenocarcinoma with others	0.201	1.904 (0.696–5.207)
AFP (ng/ml)
≤ 8.1 vs.＞ 8.1	0.308	2.388 (0.447–12.752）
CEA (ng/ml)
≤ 5 vs.＞ 5	0.006	3.109 (1.393–6.938)
CA199 (U/ml)
≤ 37 vs.＞ 37	0.045	1.589 (1.011–2.496）
CA125 (U/ml)
≤ 35 vs. ＞ 35	0.025	10.806 (1.344–86.885)
CA50
≤ 25 vs. ＞ 25	0.165	2.204 (0.723–6.728)
PD-L1
Negative vs. positive	0.777	1.106 (0.552–2.217)
HER-2
Negative vs. positive	0.517	1.406 (0.503–3.391)

Statistically significant ().